Latest Shareholder Value News

Page 9 of 311
Ora Banda Mining delivered record FY26 results with a 53% jump in gold production and doubled revenue to $807.5 million, underpinning its DRIVE to 300 growth strategy targeting 300,000 ounces annually by FY29.
Maxwell Dee
Maxwell Dee
26 Aug 2026
ParagonCare’s FY26 results show modest revenue and underlying earnings growth, overshadowed by a large credit loss provision related to the Infinity Pharmacy Group debt.
Ada Torres
Ada Torres
26 Aug 2026
L1 Long Short Fund Limited (ASX:LSF) posted a standout FY26 with a 45.4% net portfolio return, driving a 538% jump in net profit after tax to $635 million and a 22% CAGR in dividends since IPO. The fund also released its inaugural climate-related disclosures, affirming resilience amid evolving risks.
Claire Turing
Claire Turing
26 Aug 2026
Sierra Nevada Gold (ASX: SNX) has completed a $12.85 million capital raise to fund an aggressive Phase 2 drilling campaign at its As Safra Copper-Gold Project in Saudi Arabia, supported by strong institutional backing.
Maxwell Dee
Maxwell Dee
26 Aug 2026
Atlas Pearls Ltd (ASX: ATP) faced a tough FY26 with revenue down 42% to $25.8 million and a net loss of $7.9 million, driven by lower pearl quality and softer market conditions. Despite this, the company seeded a record number of oysters and declared a fully franked final dividend of 0.45 cents per share.
Ada Torres
Ada Torres
26 Aug 2026
Urbanise.com Limited reported 14.3% revenue growth to $15 million in FY2026, significantly narrowing its net loss to $0.9 million while advancing a NAB partnership pilot and launching AI features.
Sophie Babbage
Sophie Babbage
26 Aug 2026
Resimac Group Ltd delivered a 42% jump in statutory profit for FY26 despite flat revenue, driven by strong home loan growth and improved margins, while raising its final dividend to 6 cents per share.
Claire Turing
Claire Turing
26 Aug 2026
Genetic Signatures (ASX: GSS) and Microba Life Sciences (ASX: MAP) are in early talks about merging to form a larger infectious disease diagnostics entity, combining rapid pathogen detection with microbiome profiling. The proposed group would have FY2026 pro forma revenue of around A$29 million and a stronger financial footing.
Ada Torres
Ada Torres
26 Aug 2026
Mastermyne Group Limited (ASX:MYE) delivered a robust FY26 with revenue up 13% to $237.7 million and underlying profit before tax surging 148% to $15.7 million, supported by contract wins and a record order book.
Maxwell Dee
Maxwell Dee
26 Aug 2026
FAR Limited swung to a US$1.44 million profit for H1 2026, driven by contingent payments from its Senegal asset sale, and completed a substantial A$32.3 million capital return to shareholders.
Maxwell Dee
Maxwell Dee
26 Aug 2026
BCAL Diagnostics has increased its shareholding in Genetic Signatures to nearly a fifth, aiming to leverage infectious disease technology to complement its cancer detection portfolio.
Ada Torres
Ada Torres
26 Aug 2026
Woolworths Group posted solid full-year results for FY26, driven by strong Australian Food sales and complementary businesses, alongside a 15.6% increase in the fully franked final dividend.
Logan Eniac
Logan Eniac
26 Aug 2026

Browse the archive

Full archive